Shares of Lemonade Inc (NYSE: LMND) lost 8.50% Wednesday.

As of 12:02:42 est, Lemonade is currently sitting at $17.45 and dropped $1.61  so far today.

Lemonade has moved 19.40% over the last 30 days and has a YTD change of 55.00% based on the previous close.

The company is set to release earnings on 2022-08-04.

For technical charts, analysis, and more on Lemonade visit the company profile.

About Lemonade Inc

Lemonade offers renters, homeowners, and pet health insurance in the United States, contents and liability insurance in Germany and the Netherlands, and renters insurance in France, through its full-stack insurance carriers. Powered by artificial intelligence and behavioral economics, Lemonade set out to replace brokers and bureaucracy with bots and machine learning, aiming for zero paperwork and instant everything. A Certified B-Corp, Lemonade gives unused premiums to nonprofits selected by its community, during its annual Giveback. Lemonade is currently available for most of the United States, Germany, the Netherlands and France and continues to expand globally.

To get more information on Lemonade Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Lemonade Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Cigna Beats Q1 Revenue and Earnings Estimates, Raises Full Year Guidance

PepGen Goes Public in $108 Million IPO

Bausch + Lomb Raises $630 Million in IPO, Missing Expectations

Aeglea BioTherapeutics Raises $45 Million Via Registered Direct Offering

Biogen CEO Michel Vounatsos To Step Down After Commercial Failure of Alzheimer’s Drug

Decentralization Drives Progress

Stocks To Watch in 5G Wireless Growth Wave: Jeff Kagan

Betting Against Elon Musk Has Not Been Profitable